Globus Medical climbs on better-than-expected Q4, FY outlook

Globus Medical

08/01/2026 14:05

** Medical device maker Globus Medical's GMED.N shares rise 8.4% to $98.17 premarket, set to open at a record high if current gains hold

** Co expects Q4 sales of $823.2 mln vs analysts' average estimate of $776.8 mln - data compiled by LSEG

** Attributes stronger performance to spinal surgery products and enabling technologies

** GMED expects FY26 adj. EPS between $4.30 and $4.40 vs estimate of $3.82

** Three brokerages raise PT

** We think GMED is well-positioned to grow above market - Jefferies

** Nine of 15 brokerages rate the stock "buy" or higher, six "hold"; their median PT is $105 - data compiled by LSEG

** GMED shares gained 5.6% last year

 (Reporting by Utkarsh Tushar Hathi)

 ((utkarshtushar.hathi@thomsonreuters.com))